Clinical Trials in Nashville

Showing 10181-10200 of 17,403 trials

Natural History of Granulomatosis With Polyangiitis: Clinical and Genetic Biomarkers of Airway Disease NoAAC PR-03 Study

NCT03182049

The ultimate goal of this prospective natural history study is to define the natural history of the obstructive airway manifestations of Granulomatosis with polyangiitis (GPA). Additionally this proposal seeks to develop biomarkers of disease activity and define their correlation with clinical outcomes in an effort to transform clinical care and shape future drug development for this devastating rare disease.

Granulomatosis With Polyangiitis

Vanderbilt University Medical CenterStarted Dec 2020

Nashville, Tennessee, United States

COMPLETEDPhase 3< 1 mile

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor

NCT01610284

This study was a multi-center, randomized, double-blind, placebo controlled Phase III study to determine the efficacy and safety of treatment with buparlisib plus fulvestrant versus fulvestrant plus placebo in postmenopausal women with hormone Receptor-positive (HR-positive), human epidermal growth factor receptor 2-negative (HER2-negative), locally advanced or metastatic breast cancer (MBC) whose disease has progressed on or after aromatase inhibitor (AI) treatment.

Breast Cancer

Novartis Pharmaceuticals1,147 participantsStarted Aug 2012

Mobile, Alabama, United States • Phoenix, Arizona, United States • Fayetteville, Arkansas, United States +265 more locations

Natural History of Granulomatosis With Polyangiitis: Clinical and Genetic Biomarkers of Airway Disease NoAAC PR-03 Study

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor

Find Trials by Condition in Nashville

A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis

Acthar Gel for Active Systemic Lupus Erythematosus (SLE)

Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis

Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents

Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus

An Investigational Immuno-Therapy Study of Experimental Medication BMS-986242 Given in Combination With Nivolumab in Patients With Advanced Cancer

Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies

Study to Evaluate the Safety and Efficacy of CTP-656 in Patients With Cystic Fibrosis With CFTR Gating Mutations

Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A

Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05

Clinical Validation of a Molecular Test for Ciprofloxacin-Susceptibility in Neisseria Gonorrhoeae

Fractional Ablative Radiofrequency for the Treatment of Acne Scars and Wrinkles

SHARE for Persons With Chronic Conditions and Their Family Caregivers

A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant Phase

Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)

Study of Endorectal Cooling During RARP to Minimize Trauma and Promote Earlier Return to Continence